Showing 1 - 3 results of 3 for search 'E. A. Ponomarev', query time: 0.02s Refine Results
  1. 1
    EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON

    EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON by V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov

    Published 2016-12-01
    Get full text
    Article
  2. 2
    Clinical trial of fibrinselective thrombolytic pharmaceutical agent «FORTELYZIN®» (III Phase)

    Clinical trial of fibrinselective thrombolytic pharmaceutical agent «FORTELYZIN®» (III Phase) by S S Markin, A M Semenov, V A Markov, A A Nizov, E A Ponomarev, P A Lebedev

    Published 2012-03-01
    Get full text
    Article
  3. 3
    Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1

    Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1 by V. A. Markov, D. V. Duplyakov, S. L. Konstantinov, G. V. Klein, S. B. Aksentev, D. Yu. Platonov, E. V. Vyshlov, E. A. Ponomarev, R. M. Rabinovich, E. L. Makarov, E. V. Kulibaba, D. S. Yunevich, O. V. Kritskaia, E. A. Baranov, O. B. Talibov, E. A. Gerasimets

    Published 2018-12-01
    Get full text
    Article

Search Tools: